BNP Paribas Financial Markets Sells 86,832 Shares of Aspen Aerogels, Inc. (NYSE:ASPN)

BNP Paribas Financial Markets cut its holdings in shares of Aspen Aerogels, Inc. (NYSE:ASPNFree Report) by 82.7% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 18,189 shares of the construction company’s stock after selling 86,832 shares during the period. BNP Paribas Financial Markets’ holdings in Aspen Aerogels were worth $504,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in ASPN. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Aspen Aerogels by 10.3% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 14,310 shares of the construction company’s stock valued at $341,000 after acquiring an additional 1,339 shares during the last quarter. nVerses Capital LLC lifted its holdings in Aspen Aerogels by 45.0% during the 3rd quarter. nVerses Capital LLC now owns 5,800 shares of the construction company’s stock worth $161,000 after buying an additional 1,800 shares during the period. Price T Rowe Associates Inc. MD lifted its holdings in Aspen Aerogels by 15.3% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 14,580 shares of the construction company’s stock worth $257,000 after buying an additional 1,938 shares during the period. Point72 Hong Kong Ltd bought a new stake in shares of Aspen Aerogels in the 2nd quarter valued at about $84,000. Finally, Quent Capital LLC bought a new stake in shares of Aspen Aerogels in the 3rd quarter valued at about $118,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Aspen Aerogels

In related news, CEO Donald R. Young sold 63,355 shares of Aspen Aerogels stock in a transaction on Monday, September 30th. The shares were sold at an average price of $30.03, for a total value of $1,902,550.65. Following the completion of the sale, the chief executive officer now owns 483,640 shares of the company’s stock, valued at approximately $14,523,709.20. This trade represents a 11.58 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 4.30% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the company. StockNews.com upgraded Aspen Aerogels to a “sell” rating in a research report on Wednesday, November 13th. HC Wainwright restated a “buy” rating and set a $30.00 price target on shares of Aspen Aerogels in a report on Wednesday, October 16th. Roth Mkm decreased their price objective on shares of Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating for the company in a research report on Friday, November 8th. Barclays lowered their target price on shares of Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating for the company in a research note on Tuesday, November 12th. Finally, TD Cowen upped their price target on shares of Aspen Aerogels from $36.00 to $41.00 and gave the company a “buy” rating in a research report on Tuesday, August 20th. One analyst has rated the stock with a sell rating, nine have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $28.70.

Check Out Our Latest Stock Report on ASPN

Aspen Aerogels Price Performance

Shares of NYSE ASPN opened at $13.14 on Friday. The firm has a market capitalization of $1.08 billion, a P/E ratio of 1,325.33 and a beta of 2.11. The firm’s 50-day moving average price is $17.64 and its 200-day moving average price is $23.10. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27. Aspen Aerogels, Inc. has a 1-year low of $10.75 and a 1-year high of $33.15.

Aspen Aerogels Profile

(Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

See Also

Institutional Ownership by Quarter for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.